Coronado Biosciences, Inc. (CNDO) was a big mover last session, as its shares surged over 13% on the day. The surge came on solid volume too with far more shares changing hands than in a normal session. This is in conformity with the recent trend for the healthcare stock as it is now up over 40% in the past one-month time frame.
The company has seen one positive estimate revision in the last 30 days and its Zacks Consensus Estimate also moved higher over the same timeframe, suggestive of more solid trading ahead. So make sure to keep an eye on this stock going forward to see if this recent jump can translate into more strength down the road.
Coronado currently has a Zacks Rank #2 (Buy) while its Earnings ESP is negative.
Some better-ranked medical stocks include Lannett Company, Inc. (LCI), Jazz Pharmaceuticals Plc (JAZZ) and Questcor Pharmaceuticals, Inc. (QCOR). All three companies carry a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
CORONADO BIOSCIENCES INC (CNDO): Free Stock Analysis Report
LANNETT CO INC (LCI): Free Stock Analysis Report
JAZZ PHARMACEUTICALS PLC IRELAND (JAZZ): Free Stock Analysis Report
QUESTCOR PHARMACEUTICALS INC (QCOR): Free Stock Analysis Report
Zacks Investment Research
- Finance Trading
- Personal Investing Ideas & Strategies